Dr. David R. Gandara
Claim this profileUniversity of California Davis Comprehensive Cancer Center
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
11 reported clinical trials
18 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
Stage II
2Non-Small Cell Lung Cancer
Stage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials David R. Gandara is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
More about David R. Gandara
Clinical Trial Related5 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments David R. Gandara has experience with
- Pembrolizumab
- Pemetrexed
- Carboplatin
- Ramucirumab
- Pemetrexed Disodium
- Gemcitabine Hydrochloride
Breakdown of trials David R. Gandara has run
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Recurrence
Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David R. Gandara specialize in?
David R. Gandara focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is David R. Gandara currently recruiting for clinical trials?
Yes, David R. Gandara is currently recruiting for 5 clinical trials in Sacramento California. If you're interested in participating, you should apply.
Are there any treatments that David R. Gandara has studied deeply?
Yes, David R. Gandara has studied treatments such as Pembrolizumab, Pemetrexed, Carboplatin.
What is the best way to schedule an appointment with David R. Gandara?
Apply for one of the trials that David R. Gandara is conducting.
What is the office address of David R. Gandara?
The office of David R. Gandara is located at: University of California Davis Comprehensive Cancer Center, Sacramento, California 95817 United States. This is the address for their practice at the University of California Davis Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.